South Korean Box Office: 'Avengers: Age of Ultron' Tops for Third Straight Week

Avengers: Age of Ultron The Hulk Still - H 2015
Courtesy of Marvel Studios

Avengers: Age of Ultron The Hulk Still - H 2015

The Marvel feature has cashed in over $73M and is nearing the milestone score of 10M admissions.

Avengers: Age of Ultron reigned over the South Korean box office for the third straight week, hauling in 52.1 percent of weekend sales from May 8-10.

The Walt Disney Company Korea film has cashed in about $73.3 million as of Tuesday, according to the Korean Film Council's KOBIS database. Various offerings of the film including the more expensive 3D and IMAX formats have helped add to sales.

In terms of admissions, by which local industry watchers usually measure a film's box-office success, Avengers swiftly surpassed 9 million on Saturday and is nearing the 10 million mark. In local box office history, only slightly more than dozen films have drawn 10 million admissions, or a fifth of Korea's population of 50 million.

Coin Locker Girl retained its grip on second place for the second consecutive week. The local thriller handled by CJ Entertainment accounted for 17.4 percent of the market share, and has so far earned over $9.4 million. The film about two women's struggle to survive in Korea's gritty Chinatown will make its international premiere during Cannes Critics' Week that kicks off on Thursday.

Unfriended, handled by Universal Pictures International Korea, debuted in third. It grabbed 7 percent of the weekend revenue to earn over $1 million.

The horror flick was followed by another new film, Love Clinic, which finished fourth by taking 6.8 percent of the share or a little below $1 million. Distributed by Showbox/Mediaplex and WAW Pictures, the homespun sex comedy follows the uncanny romance between a male obstetrician and female urologist.

Enemies-in-Law, which debuted third last week, slipped to fifth place. The sequel to the 2011 Korean family comedy, Meet the In-Laws, is distributed by Lotte Entertainment. It accounted for 4.3 percent of the market share.